TWA
CLLS

TCI Wealth Advisors’s Cellectis CLLS Stock Holding History

TCI Wealth Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed -$3K – 1476
2018
Q2 		$3K Hold
100
– – ﹤0.01% 920
2018
Q1 		$3K Hold
100
– – ﹤0.01% 836
2017
Q4 		$3K Hold
100
– – ﹤0.01% 888
2017
Q3 		$3K Buy
+100
New +$2.59K ﹤0.01% 831

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

TCI Wealth Advisors's CLLS Position: Q3 2018 in Review

TCI Wealth Advisors sold out of Cellectis (CLLS) in Q3 2018, closing a stake of 100 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in CLLS in Q3 2017 and held it in 4 quarters. The position peaked at $3K in Q2 2018. 81 funds tracked by Wall St. Rank hold CLLS as of Q3 2018.

  • TCI Wealth Advisors reported no remaining Cellectis position as of Q3 2018 after selling out during the quarter.
  • TCI Wealth Advisors sold 100 Cellectis shares in Q3 2018, an estimated $3K.
  • TCI Wealth Advisors first reported a position in Cellectis in Q3 2017 and held it in 4 quarters.
  • TCI Wealth Advisors's Cellectis position peaked at $3K in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q3 2018.

Based on TCI Wealth Advisors's 13F filing for Q3 2018, filed 2 Nov 2018.